Olongapo City allots P20M as initial budget for COVID-19 vaccine purchase | Inquirer ºÚÁÏÉç

ºÚÁÏÉç

Olongapo City allots P20M as initial budget for COVID-19 vaccine purchase

/ 12:06 PM January 11, 2021

OLONGAPO CITY –– The city government has allocated an initial P20 million budget for the purchase of vaccines against the coronavirus disease (COVID-19).

Mayor Rolen Paulino Jr. announced this on Monday, adding that they would sacrifice the city’s budget for some infrastructure projects to get more funding for the city’s vaccination program if needed.

“Our priority, for now, is to vaccinate the whole city’s population,” he said. Based on the 2015 census, the city has 233,040 residents.

Article continues after this advertisement

In Zambales province, Dr. Noel Bueno, provincial health director, said they had yet to decide which brand of the vaccines to procure.

“Our primary consideration in choosing a brand [of vaccine] is the efficacy and safety,” Bueno told the Inquirer.

LZB
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

For more news about the novel coronavirus click
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this

MOST READ
technology
www
globalnation
business
entertainment
TAGS: Coronavirus, COVID-19, disease, Olongapo City, Philippine news updates, Regions, Vaccines

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2025 ºÚÁÏÉç | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.